Dr. Lal PathLabs (NSE:LALPATHLAB) Net Issuance of Preferred Stock : ₹0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Dr. Lal PathLabs Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Dr. Lal PathLabs's net issuance of preferred for the three months ended in Mar. 2024 was ₹0 Mil. The number is 0, which means that Dr. Lal PathLabs has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Dr. Lal PathLabs's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0 Mil.

Dr. Lal PathLabs Net Issuance of Preferred Stock Historical Data

The historical data trend for Dr. Lal PathLabs's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr. Lal PathLabs Net Issuance of Preferred Stock Chart

Dr. Lal PathLabs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

1.50

Dr. Lal PathLabs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Dr. Lal PathLabs Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Dr. Lal PathLabs Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Dr. Lal PathLabs's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr. Lal PathLabs (NSE:LALPATHLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

539524:India

Address

12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001

Website

https://www.lalpathlabs.com

Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.

Dr. Lal PathLabs (NSE:LALPATHLAB) Headlines

No Headlines